je.st
news
Johnson & Johnson, ViaCyte testing possible diabetes cure
2016-02-04 07:46:33| Biotech - Topix.net
Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder. They've already begun testing it in a small number of diabetic patients.
Tags: testing
johnson
cure
diabetes
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||